Keywords: enzo, hepatitis, drug, performs, ph, ii, study

Enzo hepatitis drug performs in Ph II study

Article | 15 October 2001

Print This

Enzo Biochem has reported preliminary Phase II data from a study ofEHT899, a candidate drug for the treatment of chronic ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in